Mr. John Miller reports

THC BIOMED INTL LTD. PROVIDES UPDATE IN CONNECTION WITH MCTO

THC Biomed Intl Ltd. is providing an update in connection with the management cease trade order (MCTO) granted by the British Columbia Securities Commission on Nov. 29, 2023. The company announced the MCTO on Nov. 30, 2023. As a result of delays to its audit, due to the lack of payment of fees to the auditor, the company's annual financial statements, and accompanying management's discussion and analysis for the fiscal year ended July 31, 2023, were not finalized by Nov. 28, 2023, being the date that such filings are due under applicable Canadian securities law requirements.

The Company has now paid the audit fees, and is waiting for confirmation from the auditor regarding the possible timing for the completion and filing of the annual filings.

The MCTO restricts management from trading in securities of the company until the annual filings are filed. Until the company files the annual filings while the MCTO is in place, it will comply with the alternative information guidelines set out in National Policy 12-203 -- Management Cease Trade Order. The guidelines, among other things, require the company to issue biweekly default status reports by way of a news release for as long as the annual filings have not been filed while the MCTO is in place. During the MCTO, the general investing public will continue to be able to trade in the company's shares.

The company confirms that, other than as disclosed in prior press releases and material change reports, there have been no material business developments since the filing on June 29, 2023, of the company's latest interim financial reports for the period ended April 30, 2023.

About THC Biomed Intl Ltd.

THC Biomed is a leading cannabis company dedicated to producing high-quality, diverse cannabis products. With a focus on innovation and consumer satisfaction, THC Biomed strives to meet the evolving needs of cannabis enthusiasts through continuous research, development and product excellence.

We seek Safe Harbor.